Cases & Deals

Bay City Capital and Panorama Capital invest in Hyperion Therapeutics

Clients Bay City Capital and Panorama Capital

Jones Day counseled Bay City Capital and Panorama Capital in connection with their purchase of $60 million of Series C Convertible Preferred Stock, along with Highland Capital Partners, NEA, Sofinnova Ventures, and WRF Capital, in a private placement by Hyperion Therapeutics, a privately held specialty biopharmaceutical company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.